Market Overview:
The global veterinary infectious disease diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of zoonotic diseases, rising demand for animal-derived food products, and growing awareness about animal health and hygiene. The immunodiagnostics segment is expected to dominate the market during the forecast period owing to its high accuracy and reliability. The molecular diagnostics segment is projected to grow at a higher CAGR than other technologies during the forecast period as it offers faster, more accurate, and more reliable results as compared with other diagnostic techniques. In terms of application, hospitals are expected to account for the largest share of the global veterinary infectious disease diagnostics market in 2018. This can be attributed primarilyto th e increasing number of outbreaks of zoonotic diseases in hospitals acrossthe world .
Product Definition:
Veterinary infectious disease diagnostics is the process of identifying and diagnosing an infectious disease in a veterinary patient. This process can involve a variety of techniques, including blood tests, cultures, and imaging studies. The importance of veterinary infectious disease diagnostics lies in the fact that many diseases can be treated more effectively if they are caught early. Additionally, some diseases pose a serious threat to public health and need to be monitored carefully.
Immunodiagnostics:
The global immunodiagnostics market is expected to grow at a lucrative rate during the forecast period. The key drivers attributing to its rapid growth include rising pet population, increasing expenditure on pets and companion animals by owners, and growing awareness among veterinary practitioners regarding efficient diagnosis of infectious diseases in animals.
Immunodiagnostic tests are used for the detection of various infectious diseases in companion animals as well as food chains such as meat-eating pests or wildlife species.
Molecular Diagnostics:
Molecular diagnostics is a set of procedures used to identify and analyze the genetic material (DNA) of an infectious agent. It is one of the most important tools in medical science as it helps in understanding disease etiology, epidemiology, pathogenesis, and transmission routes. This technique has been applied successfully for human diseases like cancer & HIV infection as well animal diseases like influenza & tuberculosis.
Application Insights:
Based on application, the market is segmented into lab, hospital and clinics, and others. The lab held the largest share of over 70% in 2017. This large share can be attributed to factors such as rising demand for laboratory tests for infectious diseases diagnosis across various applications such as food safety & animal health testing. Moreover, increasing government funding towards research related to infectious diseases is also expected to drive growth during the forecast period.
The hospital segment is anticipated to witness a lucrative CAGR of XX% from 2018 to 2030 owing to factors such as an increase in human infections with zoonotic pathogens that pose a significant risk for humans worldwide which eventually results in increased spending on veterinary healthcare along with other expenses incurred by humans globally resulting in higher chances of being hospitalized globally thereby driving demand for VHD diagnostics at hospitals or clinics where these patients are treated or quarantined respectively thus contributing towards revenue generation at highest rate during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in research and development, and increasing prevalence of zoonotic diseases. The Asia Pacific is expected to grow at a lucrative rate during the forecast period due to increase in R&D expenditure by governments as well as private companies for infectious disease diagnostics coupled with rising awareness among people about early diagnosis. Moreover, growing demand for meat from developing countries such as China and India will drive growth over this period. In addition, rise in international travel has increased risk of exposure to zoonotic diseases which is further fueling growth over this period (8).
Moreover, increasing incidence of highly contagious yet preventable animal diseases such as avian influenza across Asian countries including China & Japan are projectededly increase spending on veterinary healthcare services thereby driving growth during the forecast period (9).
Growth Factors:
- Increasing demand for meat and dairy products is expected to drive the growth of veterinary infectious disease diagnostics market.
- Rising awareness about animal health and zoonotic diseases is another major factor that would fuel the demand for veterinary infectious disease diagnostics market in near future.
- Growing number of outbreaks of livestock diseases is anticipated to create lucrative opportunities for the players operating in Veterinary Infectious Disease Diagnostics market during forecast period.
- Technological advancements in diagnostic tools and increasing R&D investments are likely to boost the growth of Veterinary Infectious Disease Diagnostics market over next few years. 5) rising trend of pet ownership across globe would also propel the demand for veterinary infectious disease diagnostics during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Veterinary Infectious Disease Diagnostics Market Research Report
By Type
Immunodiagnostics, Molecular Diagnostics, Other Technologies
By Application
Lab, Hospital, Clinics, Others
By Companies
DEXX Laboratories, Inc., Zoetis, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., Neogen Corporation, Virbac, IDVet, Randox Laboratories, Ltd., Heska Corporation, Creative Diagnostics, URIT Medical Electronic Group Co., Ltd, NTBIO Diagnostics, Inc., Bio-X Diagnostics, Agrolabo S.p.A, Eurolyser Diagnostica, Eurofins Technologies, MEGACOR Diagnostik GmbH, AusDiagnostics Pty, Ltd., Demedetic Diagnostics GmbH, Chembio Diagnostic Systems, Inc., DRG Diagnostics GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Veterinary Infectious Disease Diagnostics Market Report Segments:
The global Veterinary Infectious Disease Diagnostics market is segmented on the basis of:
Types
Immunodiagnostics, Molecular Diagnostics, Other Technologies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lab, Hospital, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- DEXX Laboratories, Inc.
- Zoetis, Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
- Neogen Corporation
- Virbac
- IDVet
- Randox Laboratories, Ltd.
- Heska Corporation
- Creative Diagnostics
- URIT Medical Electronic Group Co., Ltd
- NTBIO Diagnostics, Inc.
- Bio-X Diagnostics
- Agrolabo S.p.A
- Eurolyser Diagnostica
- Eurofins Technologies
- MEGACOR Diagnostik GmbH
- AusDiagnostics Pty, Ltd.
- Demedetic Diagnostics GmbH
- Chembio Diagnostic Systems, Inc.
- DRG Diagnostics GmbH
Highlights of The Veterinary Infectious Disease Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunodiagnostics
- Molecular Diagnostics
- Other Technologies
- By Application:
- Lab
- Hospital
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Veterinary Infectious Disease Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Veterinary Infectious Disease Diagnostics (VID) is a company that provides diagnostic services for infectious diseases in animals. Services include testing for viruses, bacteria, and parasites; providing information on disease outbreaks; and providing guidance on treatment. VID also offers consulting services to veterinarians and animal owners.
Some of the major companies in the veterinary infectious disease diagnostics market are DEXX Laboratories, Inc., Zoetis, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., Neogen Corporation, Virbac, IDVet, Randox Laboratories, Ltd., Heska Corporation, Creative Diagnostics, URIT Medical Electronic Group Co., Ltd, NTBIO Diagnostics, Inc., Bio-X Diagnostics, Agrolabo S.p.A, Eurolyser Diagnostica, Eurofins Technologies, MEGACOR Diagnostik GmbH, AusDiagnostics Pty, Ltd., Demedetic Diagnostics GmbH, Chembio Diagnostic Systems, Inc., DRG Diagnostics GmbH.
The veterinary infectious disease diagnostics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Veterinary Infectious Disease Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Veterinary Infectious Disease Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Veterinary Infectious Disease Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Veterinary Infectious Disease Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Veterinary Infectious Disease Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Veterinary Infectious Disease Diagnostics Market Size and Y-o-Y Growth
4.5.2 Veterinary Infectious Disease Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Veterinary Infectious Disease Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Veterinary Infectious Disease Diagnostics Market Size Forecast by Type
5.2.1 Immunodiagnostics
5.2.2 Molecular Diagnostics
5.2.3 Other Technologies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Veterinary Infectious Disease Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Veterinary Infectious Disease Diagnostics Market Size Forecast by Applications
6.2.1 Lab
6.2.2 Hospital
6.2.3 Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Veterinary Infectious Disease Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Veterinary Infectious Disease Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Veterinary Infectious Disease Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Veterinary Infectious Disease Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Veterinary Infectious Disease Diagnostics Market Size Forecast by Type
9.6.1 Immunodiagnostics
9.6.2 Molecular Diagnostics
9.6.3 Other Technologies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Veterinary Infectious Disease Diagnostics Market Size Forecast by Applications
9.10.1 Lab
9.10.2 Hospital
9.10.3 Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Veterinary Infectious Disease Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Veterinary Infectious Disease Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Veterinary Infectious Disease Diagnostics Market Size Forecast by Type
10.6.1 Immunodiagnostics
10.6.2 Molecular Diagnostics
10.6.3 Other Technologies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Veterinary Infectious Disease Diagnostics Market Size Forecast by Applications
10.10.1 Lab
10.10.2 Hospital
10.10.3 Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Veterinary Infectious Disease Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Veterinary Infectious Disease Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Veterinary Infectious Disease Diagnostics Market Size Forecast by Type
11.6.1 Immunodiagnostics
11.6.2 Molecular Diagnostics
11.6.3 Other Technologies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Veterinary Infectious Disease Diagnostics Market Size Forecast by Applications
11.10.1 Lab
11.10.2 Hospital
11.10.3 Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Veterinary Infectious Disease Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Veterinary Infectious Disease Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Veterinary Infectious Disease Diagnostics Market Size Forecast by Type
12.6.1 Immunodiagnostics
12.6.2 Molecular Diagnostics
12.6.3 Other Technologies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Veterinary Infectious Disease Diagnostics Market Size Forecast by Applications
12.10.1 Lab
12.10.2 Hospital
12.10.3 Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Veterinary Infectious Disease Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Veterinary Infectious Disease Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Veterinary Infectious Disease Diagnostics Market Size Forecast by Type
13.6.1 Immunodiagnostics
13.6.2 Molecular Diagnostics
13.6.3 Other Technologies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Veterinary Infectious Disease Diagnostics Market Size Forecast by Applications
13.10.1 Lab
13.10.2 Hospital
13.10.3 Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Veterinary Infectious Disease Diagnostics Market: Competitive Dashboard
14.2 Global Veterinary Infectious Disease Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 DEXX Laboratories, Inc.
14.3.2 Zoetis, Inc.
14.3.3 QIAGEN N.V.
14.3.4 Thermo Fisher Scientific, Inc.
14.3.5 Neogen Corporation
14.3.6 Virbac
14.3.7 IDVet
14.3.8 Randox Laboratories, Ltd.
14.3.9 Heska Corporation
14.3.10 Creative Diagnostics
14.3.11 URIT Medical Electronic Group Co., Ltd
14.3.12 NTBIO Diagnostics, Inc.
14.3.13 Bio-X Diagnostics
14.3.14 Agrolabo S.p.A
14.3.15 Eurolyser Diagnostica
14.3.16 Eurofins Technologies
14.3.17 MEGACOR Diagnostik GmbH
14.3.18 AusDiagnostics Pty, Ltd.
14.3.19 Demedetic Diagnostics GmbH
14.3.20 Chembio Diagnostic Systems, Inc.
14.3.21 DRG Diagnostics GmbH
